Tarsus Pharmaceuticals (TARS) announced the appointment of Elizabeth Yeu, M.D., as Chief Medical Officer, effective November 4, 2024. Dr. Yeu has served as Tarsus’ Chief Medical Advisor since 2020 and as a Board member since 2021. In this new role, she will be responsible for leading the strategy, direction and execution of the Company’s new Medical Organization comprising the medical affairs and pharmacovigilance teams, including evidence generation, medical education and oversight of patient safety. She joins the Executive Team, reporting to Tarsus CEO and Chairman, Bobby Azamian, M.D., Ph.D., and has transitioned off the Company’s Board of Directors. Yeu serves as a partner and practicing ophthalmologist at Virginia Eye Consultants, where she will continue her clinical practice.
